Luteolin exhibits anti-inflammatory effects by blocking the activity of heat shock protein 90 in macrophages - PubMed (original) (raw)
. 2014 Jan 3;443(1):326-32.
doi: 10.1016/j.bbrc.2013.11.122. Epub 2013 Dec 7.
Affiliations
- PMID: 24321097
- DOI: 10.1016/j.bbrc.2013.11.122
Luteolin exhibits anti-inflammatory effects by blocking the activity of heat shock protein 90 in macrophages
Dan Chen et al. Biochem Biophys Res Commun. 2014.
Abstract
Septic diseases represent the prevalent complications in intensive care units. Luteolin, a plant flavonoid, has potent anti-inflammatory properties; however, the molecular mechanism beneath luteolin mediated immune modulation remains unclear. Here in vitro investigations showed that luteolin dose-dependently inhibited LPS-triggered secretion and relocation of high mobility group B-1 (HMGB1) and LPS-induced production of tumor necrosis factor alpha (TNF-α) and nitric oxide (NO) in macrophages. The mechanism analysis demonstrated that luteolin reduced the release of HMGB1 through destabilizing c-Jun and suppressed HMGB1-induced aggravation of inflammatory cascade through reducing Akt protein level. As an inhibitor of Hsp90, luteolin destabilized Hsp90 client protein c-Jun and Akt. In vivo investigations showed that luteolin effectively protected mice from lipopolysaccharide (LPS)-induced lethality. In conclusion, the present study suggested that luteolin may act as a potential therapeutic reagent for treating septic diseases.
Keywords: HMGB1; Heat shock protein 90; High mobility group B-1; Lipopolysaccharide; Luteolin; Macrophage; RAGE; c-Jun; high mobility group B-1; receptor for advanced glycation end products.
Copyright © 2013 Elsevier Inc. All rights reserved.
Similar articles
- Luteolin and chicoric acid synergistically inhibited inflammatory responses via inactivation of PI3K-Akt pathway and impairment of NF-κB translocation in LPS stimulated RAW 264.7 cells.
Park CM, Jin KS, Lee YW, Song YS. Park CM, et al. Eur J Pharmacol. 2011 Jun 25;660(2-3):454-9. doi: 10.1016/j.ejphar.2011.04.007. Epub 2011 Apr 15. Eur J Pharmacol. 2011. PMID: 21513709 - Inhibition of LPS-stimulated pathways in macrophages by the flavonoid luteolin.
Xagorari A, Roussos C, Papapetropoulos A. Xagorari A, et al. Br J Pharmacol. 2002 Aug;136(7):1058-64. doi: 10.1038/sj.bjp.0704803. Br J Pharmacol. 2002. PMID: 12145106 Free PMC article. - A Dalbergia odorifera extract improves the survival of endotoxemia model mice by inhibiting HMGB1 release.
Choi HS, Park JA, Hwang JS, Ham SA, Yoo T, Lee WJ, Paek KS, Shin HC, Lee CH, Seo HG. Choi HS, et al. BMC Complement Altern Med. 2017 Apr 12;17(1):212. doi: 10.1186/s12906-017-1725-0. BMC Complement Altern Med. 2017. PMID: 28403838 Free PMC article. - Effects of luteolin on sepsis: A comprehensive systematic review.
Vajdi M, Karimi A, Karimi M, Abbasalizad Farhangi M, Askari G. Vajdi M, et al. Phytomedicine. 2023 May;113:154734. doi: 10.1016/j.phymed.2023.154734. Epub 2023 Feb 26. Phytomedicine. 2023. PMID: 36898254 Review. - Luteolin as an anti-inflammatory and neuroprotective agent: A brief review.
Nabavi SF, Braidy N, Gortzi O, Sobarzo-Sanchez E, Daglia M, Skalicka-Woźniak K, Nabavi SM. Nabavi SF, et al. Brain Res Bull. 2015 Oct;119(Pt A):1-11. doi: 10.1016/j.brainresbull.2015.09.002. Epub 2015 Sep 8. Brain Res Bull. 2015. PMID: 26361743 Review.
Cited by
- QHRD106 ameliorates ischemic stroke injury as a long-acting tissue kallikrein preparation.
Xu SY, Jia JQ, Sun M, Bao XY, Xia SN, Shu S, Liu PY, Ji SL, Ye L, Cao X, Xu Y. Xu SY, et al. iScience. 2023 Jul 3;26(7):107268. doi: 10.1016/j.isci.2023.107268. eCollection 2023 Jul 21. iScience. 2023. PMID: 37496671 Free PMC article. - Plectranthus ecklonii Benth: A Comprehensive Review Into its Phytochemistry and Exerted Biological Activities.
Antão AR, Bangay G, Domínguez-Martín EM, Díaz-Lanza AM, Ríjo P. Antão AR, et al. Front Pharmacol. 2021 Nov 30;12:768268. doi: 10.3389/fphar.2021.768268. eCollection 2021. Front Pharmacol. 2021. PMID: 34916943 Free PMC article. Review. - Plant-derived immunomodulators: an insight on their preclinical evaluation and clinical trials.
Jantan I, Ahmad W, Bukhari SN. Jantan I, et al. Front Plant Sci. 2015 Aug 25;6:655. doi: 10.3389/fpls.2015.00655. eCollection 2015. Front Plant Sci. 2015. PMID: 26379683 Free PMC article. Review. - Anti-Inflammatory Activity of Citrus bergamia Derivatives: Where Do We Stand?
Ferlazzo N, Cirmi S, Calapai G, Ventura-Spagnolo E, Gangemi S, Navarra M. Ferlazzo N, et al. Molecules. 2016 Sep 23;21(10):1273. doi: 10.3390/molecules21101273. Molecules. 2016. PMID: 27669206 Free PMC article. Review. - Luteolin decreases atherosclerosis in LDL receptor-deficient mice via a mechanism including decreasing AMPK-SIRT1 signaling in macrophages.
Li J, Dong JZ, Ren YL, Zhu JJ, Cao JN, Zhang J, Pan LL. Li J, et al. Exp Ther Med. 2018 Sep;16(3):2593-2599. doi: 10.3892/etm.2018.6499. Epub 2018 Jul 20. Exp Ther Med. 2018. PMID: 30186491 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous